Health
Using two different viruses to tackle tumors – News-Medical.net
An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines.
An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in experiments on mice with cancer in order to stimulate their immune system to attack the tumor. The approach is now being tested in clinical studies.
Making use of the immune system as an ally in the fight against cancer forms the basis of a wide range of modern cancer therapies. One…
-
Business21 hours agoWarning! These ASX 200 shares were just downgraded
-
Business14 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business11 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business14 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.